Literature DB >> 18466334

Cell cycle-driven neuronal apoptosis specifically linked to amyloid peptide Abeta1-42 exposure is not exacerbated in a mouse model of presenilin-1 familial Alzheimer's disease.

Bilal Malik1, Antonio Currais, Salvador Soriano.   

Abstract

We have shown previously that beta-catenin and cyclin D1 are up-regulated in cortical neurons from homozygous mice carrying the familial Alzheimer's disease (FAD) presenilin-1 M146V mutation in a knock-in model (PS1 KI(M146V) mice), leading to cell cycle-associated apoptosis. Here, we have aimed to determine (i) whether this phenotype is present in heterozygous PS1 KI(M146V) mice, which reflects more accurately the PS1 FAD condition in humans and (ii) whether Abeta(1-42), which is invariably present in the PS1 FAD brain and is thought to affect neuronal cell cycle kinetics, may contribute to the abnormal cell cycle/cell death phenotype seen in PS1 KI(M146V) mice. We demonstrate that cell cycle-linked apoptosis occurs in heterozygous PS1 KI(M146V) post-mitotic neurons. In addition, there is a significant Abeta-associated increase in cell cycle and cell death that is not further modified by the PS1 KI(M146V) mutation. Our results are consistent with a cell cycle-associated neurodegeneration model in the PS1 FAD brain in which the loss of PS1-dependent beta-catenin regulatory function is sufficient to commit susceptible neurons to an abortive cell cycle, and may act synergistically with the Abeta cytotoxic challenge present in the PS1 FAD brain to expand the neuronal population susceptible to cell cycle-driven apoptosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18466334     DOI: 10.1111/j.1471-4159.2008.05446.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

Review 1.  The neuronal cell cycle as a mechanism of pathogenesis in Alzheimer's disease.

Authors:  Antonio Currais; Tibor Hortobágyi; Salvador Soriano
Journal:  Aging (Albany NY)       Date:  2009-04-28       Impact factor: 5.682

2.  Regulator of Cell Cycle (RGCC) Expression During the Progression of Alzheimer's Disease.

Authors:  Scott E Counts; Elliott J Mufson
Journal:  Cell Transplant       Date:  2016-11-30       Impact factor: 4.064

3.  A new and simple approach for genotyping Alzheimer's disease presenilin-1 mutant knock-in mice.

Authors:  Vanessa Gautheron; Alexandra Auffret; Mark P Mattson; Jean Mariani; Béatrice Vernet-der Garabedian
Journal:  J Neurosci Methods       Date:  2009-05-22       Impact factor: 2.390

4.  Gene expression analysis reveals early dysregulation of disease pathways and links Chmp7 to pathogenesis of spinal and bulbar muscular atrophy.

Authors:  Bilal Malik; Helen Devine; Rickie Patani; Albert R La Spada; Michael G Hanna; Linda Greensmith
Journal:  Sci Rep       Date:  2019-03-05       Impact factor: 4.379

5.  Nrdp1 is involved in hippocampus apoptosis in cardiopulmonary bypass-induced cognitive dysfunction via the regulation of ErbB3 protein levels.

Authors:  Jie Zheng; Su Min; Bin Hu; Qin Liu; Yunqiang Wan
Journal:  Int J Mol Med       Date:  2019-01-28       Impact factor: 4.101

6.  Co-induction of the heat shock response ameliorates disease progression in a mouse model of human spinal and bulbar muscular atrophy: implications for therapy.

Authors:  Bilal Malik; Niranjanan Nirmalananthan; Anna L Gray; Albert R La Spada; Michael G Hanna; Linda Greensmith
Journal:  Brain       Date:  2013-02-07       Impact factor: 13.501

7.  The PI3K-Akt-mTOR pathway regulates Abeta oligomer induced neuronal cell cycle events.

Authors:  Kiran Bhaskar; Megan Miller; Alexandra Chludzinski; Karl Herrup; Michael Zagorski; Bruce T Lamb
Journal:  Mol Neurodegener       Date:  2009-03-16       Impact factor: 14.195

8.  The expression of apoptosis inducing factor (AIF) is associated with aging-related cell death in the cortex but not in the hippocampus in the TgCRND8 mouse model of Alzheimer's disease.

Authors:  Wenfeng Yu; Mathilde Bonnet; Mark Farso; Keran Ma; Jean-Guy Chabot; Elisabeth Martin; Alicia Torriglia; Zhizhong Guan; JoAnne McLaurin; Rémi Quirion; Slavica Krantic
Journal:  BMC Neurosci       Date:  2014-06-10       Impact factor: 3.288

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.